Position paper on the management of patients with obstructive sleep apnea and hypertension: Joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on Obstructive Sleep Apnea.
Parati, Gianfranco a,b; Lombardi, Carolina b; Hedner, Jan c; Bonsignore, Maria R. d; Grote, Ludger c; Tkacova, Ruzena e; Levy, Patrick f; Riha, Renata g; Bassetti, Claudio h; Narkiewicz, Krzysztof i; Mancia, Giuseppe a; McNicholas, Walter T. j; on behalf of the EU COST ACTION B26 members
Journal of Hypertension.
30(4):633-646, April 2012.
(Format: HTML, PDF)
This article is aimed at addressing the current state of the art in epidemiology, pathophysiology, diagnostic procedures and treatment options for appropriate management of obstructive sleep apnea (OSA) in cardiovascular (particularly hypertensive) patients, as well as for the management of cardiovascular diseases (particularly arterial hypertension) in OSA patients. The present document is the result of the work done by a panel of experts participating in the European Union COST (COoperation in Scientific and Technological research) ACTION B26 on OSA, with the endorsement of the European Respiratory Society (ERS) and the European Society of Hypertension (ESH). These recommendations are particularly aimed at reminding cardiovascular experts to consider the occurrence of sleep-related breathing disorders in patients with high blood pressure. They are at the same time aimed at reminding respiration experts to consider the occurrence of hypertension in patients with respiratory problems at night.
(C) 2012 Lippincott Williams & Wilkins, Inc.